dissolvable semaglutide Weekly GLP-1 Injection vs Daily Oral: and Tirzepatide – PlexusDx Compounded Semaglutide – BloomMD

Description

On May 1, 2026, the FDA sent a warning letter to Harbin Jixianglong Biotech Co., a semaglutide API manufacturer previously included on the agencys green list

Study design and baseline profile for adults with type 2 diabetes in the once-weekly subcutaneous SEmaglutide randomized PRAgmatic (SEPRA) trial

Mechanistic studies suggest that combined receptor activation may influence multiple components of glucose homeostasis, including insulin secretion pathways, peripheral insulin signaling, and hepatic glucose metabolism

In their respective phase 3 trials, Wegovy pill produced a slightly larger average weight loss (around 13.6% over 64 weeks) than Foundayo (between 11.2% & 12.4% over 72 weeks at the highest tested dose)